Glucose-responsive insulin-delivery platforms that are sensitive to dynamic glucose concentration fluctuations and provide both rapid and prolonged insulin release have great potential to control hyperglycemia and avoid hypoglycemia diabetes. Christoph Hagemeyer discusses biodegradable and charge-switchable phytoglycogen nanoparticles capable of glucose-stimulated insulin release.
Read the Study
Image courtesy of interviewee
